ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 240 filers reported holding ISHARES TR in Q2 2013. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $12,240,294,000 | +10.6% | 86,618 | -0.9% | 5.97% | +5.9% |
| Q4 2016 | $11,064,985,000 | -2.4% | 87,382 | -1.2% | 5.64% | -5.1% |
| Q3 2016 | $11,337,775,000 | +778.4% | 88,440 | +1663.2% | 5.94% | +761.4% |
| Q2 2016 | $1,290,710,000 | -26.1% | 5,016 | -2.9% | 0.69% | -20.2% |
| Q4 2015 | $1,747,324,000 | +13807.4% | 5,164 | -84.8% | 0.86% | -85.7% |
| Q2 2015 | $12,564,000 | +3.3% | 33,876 | -2.0% | 6.06% | +5.1% |
| Q1 2015 | $12,163,000 | +13.5% | 34,555 | -0.9% | 5.77% | +15.2% |
| Q4 2014 | $10,721,000 | +12.0% | 34,855 | -2.8% | 5.01% | -0.1% |
| Q3 2014 | $9,571,000 | +4.4% | 35,868 | -0.3% | 5.01% | +11.8% |
| Q2 2014 | $9,171,000 | +11.5% | 35,992 | -0.8% | 4.48% | +2.1% |
| Q1 2014 | $8,223,000 | -1.0% | 36,295 | -0.9% | 4.39% | +1.9% |
| Q4 2013 | $8,306,000 | +5.3% | 36,629 | -1.5% | 4.31% | -4.8% |
| Q3 2013 | $7,887,000 | +14.3% | 37,186 | -2.8% | 4.53% | +13.5% |
| Q2 2013 | $6,901,000 | – | 38,257 | – | 3.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |